A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

RAYUS Radiology Quality Institute Distinguished Nationally by Centers for Medicare & Medicaid

RAYUS Radiology reports, CDI Quality Institute, a non-profit affiliate, one of the nation’s leading national subspecialty providers for advanced diagnostic and interventional radiology services, once again qualified as a Provider-led entity (PLE) for the Medicare Appropriate Use Criteria (AUC) Program with the Centers for Medicare & Medicaid Services (CMS).

PLE designation from CMS, the largest healthcare payor in the United States, is granted to a select group of organizations nationwide who are tasked with providing real-time clinical guidance to treating physicians ordering diagnostic imaging procedures such as MRI, CT and PET exams. Currently, only 22 federally qualified organizations nationwide hold the notable designation that the Quality Institute first earned in 2016.

The Quality Institute is supported by more than 250 sub-specialty trained radiologists and top specialists within RAYUS’ growing nationwide network. Since its inception in 2003, the Quality Institute has helped define quality measures to ensure patients receive the right diagnostic test or radiological procedure at the right time and, in turn, reduce any unnecessary care – and unnecessary health care spend.

“We are privileged to be among such an illustrious and highly skilled group of pioneers in the development of appropriate use criteria for diagnostic imaging,” said RAYUS Radiology Chief Executive Officer Kim Tzoumakas. “The RAYUS nationwide network of clinical experts is growing rapidly and, as a result, the evidence-based knowledge that contributes to our ability to help provide the highest quality care is growing along with us.”

Starting in 2023, if a newly released draft rule is enacted as written, all clinicians will be required to consult AUC, like those developed by the RAYUS Quality Institute, when ordering the most advanced imaging tests (MRI and CT) under Medicare coverage guidelines.

The RAYUS Quality Institute and its robust clinical library provide high-level quality support to the physician, medical center and research communities, including providing summary criteria documents distributed to ordering physicians and producing The Consult, a quarterly publication of the Quality Institute for clinicians.  Additionally, developed criteria are licensed to AIM Specialty Health, a subsidiary of Anthem, that serves more than 52M members and 330K ordering physicians nationwide, and Infinx Healthcare.

“All of us involved with our Quality Institute’s work in providing best-practice utilization guidelines and other clinical decision support tools are proud to be an important resource to our radiologists, our referring physicians, and our patients in continuing to advance the level of care,” said Dr. Thomas Gilbert, RAYUS Radiology’s Chief Clinical Officer.

Both the Quality Institute and the affiliated RAYUS Radiology network grew from the well-established roots of the former Center for Diagnostic Imaging (CDI). CDI became RAYUS Radiology in June as part of national rebranding and associated ‘SHINE ON’ campaign celebrating CDI’s distinguished 40-year legacy in the radiological field, its people and the ongoing national growth and expansion planned for the network.


Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy